2011 Fiscal Year Final Research Report
Preclinical study for the therapeutic application of botulinum neurotoxin to intractable brain disorders.
Project/Area Number |
21380188
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Applied veterinary science
|
Research Institution | Osaka Prefecture University |
Principal Investigator |
KOZAKI Syunji 大阪府立大学, 生命環境科学研究科, 教授 (10109895)
|
Co-Investigator(Kenkyū-buntansha) |
TAKEUCHI Tadayoshi 大阪府立大学, 生命環境科学研究科・獣医学専攻, 教授 (00171611)
MIYAKE Masami 大阪府立大学, 生命環境科学研究科・獣医学専攻, 教授 (10251175)
KATOH Keiko 京都産業大学, 総合生命科学部, 教授 (90252684)
NAKAJIMA Hidemitsu 大阪府立大学, 生命環境科学研究科・獣医学専攻, 准教授 (30405360)
|
Project Period (FY) |
2009 – 2011
|
Keywords | 疾病予防・制御 / 新規治療薬開発 |
Research Abstract |
To explore the possible clinical applications of botulinum neurotoxin to intractable brain disorders, we investigated whether or not the benefits of A2-botulinum neurotoxin(A2NTX) or cell-permeable C3 enzyme(Tat-C3) are exerted in several intractable brain disorders-model in rodents. Here we show the potent effectiveness of A2NTX against several types of seizer in mice or of 6-OHDA-elicited parkinsonian-like motor dysfunctions in rats. Additionally, preliminary study using brain ischemia indicates the neuroprotective effects in rats treated with Tat-C3.These results suggest that both A2NTX and Tat-C3 may indicate the beneficial possibility of medical treatments with intractable brain disorders such as epilepsy, Parkinson disease, and ischemic stroke.
|
-
[Journal Article] A rapid, targeted, neuron-selective, in vivo knockdown following a single intracerebroventricular injection of a novel chemically modified siRNA in the adult rat brain2012
Author(s)
Nakajima, H., Kubo, T., Semi, Y., Itakura, M., Kuwamura, M., Izawa, T., Azuma, YT., Takeuchi, T.
-
Journal Title
J. Biotech
Volume: 157
Pages: 326-333
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines2010
Author(s)
Nochi T., Yuki Y., Takahashi H., Sawada S., Mejima., Kohda T., Harada N, Kong IG., Sato A., Kataoka N., Tokuhara D., Kurokawa S., Tsukada H., Kozaki S., Akiyoshi K., Kiyono H.
-
Journal Title
Nature Mater
Volume: 9
Pages: 572-578
Peer Reviewed
-
-
[Journal Article] Characterization of the D/C mozaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan2010
Author(s)
Nakamura, K., Kohda, T., Umeda, K., Tamamoto, H., Mukamoto, M., Kozaki, S.
-
Journal Title
Vet Microbiol
Volume: 140
Pages: 147-154
Peer Reviewed
-
-
[Journal Article] Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential(CMAP)2009
Author(s)
Torii, Y., Takahashi, M., Ishida, S., Goto, Y., Nakahira, S., Harakawa, T., Kaji, R., Kozaki, S., Ginnaga, A.
-
Journal Title
Toxicon
Volume: 55
Pages: 662-665
Peer Reviewed
-
-
-
[Presentation] An in vitro model system for studying Clostridium perfringens type A infection2011
Author(s)
Hoshi, H., Kondo, K., Oda, M., Nagahama, M., Yamamoto, S., Kamata, Y., Miyake, M.
Organizer
International Union Microbiologi cal Sciences 2011 Congress
Place of Presentation
札幌
Year and Date
20110900
-
-
-
-
-
-
-
-
-
-
-
-
-
-